Ra-223
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ra-223, covering 2021-09-09 to 2021-09-09. Get the full timeline:
Most recent: Clinical Trial Update: The Combination Therapy With Ra-223 and Enzalutamide [Phase 2]